Abstract
Dyslipidemia is a chronic non-communicable disease (CNCD), induced by abnormalities in lipid metabolism resulting from excess intake of cholesterol, trans and saturated fats. Dyslipidemia is indicated by increased plasma total cholesterol, low-density lipoprotein (LDL) and triglyceride levels, and lower high-density lipoprotein (HDL) levels. Common treatments for dyslipidemia do not indicate ideal plasma cholesterol levels for every patient, which means better treatment is required. Some species
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have